• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多药耐药结核病不良结局预测模型。

Predictive model of unfavorable outcomes for multidrug-resistant tuberculosis.

机构信息

Universidade de São Paulo. Escola de Enfermagem de Ribeirão Preto. Ribeirão Preto, SP, Brasil.

Universidade de São Paulo. Faculdade de Medicina de Ribeirão Preto. Ribeirão Preto, SP, Brasil.

出版信息

Rev Saude Publica. 2019 Sep 23;53:77. doi: 10.11606/s1518-8787.2019053001151. eCollection 2019.

DOI:10.11606/s1518-8787.2019053001151
PMID:31553380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6752648/
Abstract

OBJECTIVE

to analyze the temporal trend, identify the factors related and elaborate a predictive model for unfavorable treatment outcomes for multidrug-resistant tuberculosis (MDR-TB).

METHODS

Retrospective cohort study with all cases diagnosed with MDR-TB between the years 2006 and 2015 in the state of São Paulo. The data were collected from the state system of TB cases notifications (TB-WEB). The temporal trend analyzes of treatment outcomes was performed through the Prais-Winsten analysis. In order to verify the factors related to the unfavorable outcomes, abandonment, death with basic cause TB and treatment failure, the binary logistic regression was used. Pictorial representations of the factors related to treatment outcome and their prognostic capacity through the nomogram were elaborated.

RESULTS

Both abandonment and death have a constant temporal tendency, whereas the failure showed it as decreasing. Regarding the risk factors for such outcomes, using illicit drugs doubled the odds for abandonment and death. Besides that, being diagnosed in emergency units or during hospitalizations was a risk factor for death. On the contrary, having previous multidrug-resistant treatments reduced the odds for the analyzed outcomes by 33%. The nomogram presented a predictive model with 65% accuracy for dropouts, 70% for deaths and 80% for failure.

CONCLUSIONS

The modification of the current model of care is an essential factor for the prevention of unfavorable outcomes. Through predictive models, as presented in this study, it is possible to develop patient-centered actions, considering their risk factors and increasing the chances for cure.

摘要

目的

分析时间趋势,确定相关因素,并建立耐多药结核病(MDR-TB)不良治疗结局的预测模型。

方法

这是一项回顾性队列研究,纳入了 2006 年至 2015 年在圣保罗州诊断为 MDR-TB 的所有病例。数据来自州结核病病例报告系统(TB-WEB)。通过 Prais-Winsten 分析对治疗结局的时间趋势进行分析。为了验证与不良结局相关的因素,包括放弃治疗、因基本病因 TB 死亡和治疗失败,采用二元逻辑回归分析。通过列线图阐述了与治疗结局相关的因素及其预后能力的图示表示。

结果

放弃治疗和死亡均呈现出持续的时间趋势,而治疗失败则呈现出下降的趋势。在与这些结局相关的风险因素中,使用非法药物使放弃治疗和死亡的几率增加了一倍。此外,在急诊部门或住院期间诊断为结核病是死亡的风险因素。相反,以前有过耐多药治疗则会使分析结局的几率降低 33%。列线图预测模型对辍学的准确率为 65%,对死亡的准确率为 70%,对失败的准确率为 80%。

结论

改变当前的护理模式是预防不良结局的关键因素。通过预测模型,如本研究中所示,可以制定以患者为中心的治疗方案,考虑其风险因素,增加治愈的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc0/6752648/dbf519cb381c/1518-8787-rsp-53-77-gf02-pt.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc0/6752648/e0c713e22eb3/1518-8787-rsp-53-77-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc0/6752648/28ba8c39c27e/1518-8787-rsp-53-77-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc0/6752648/a70186751180/1518-8787-rsp-53-77-gf01-pt.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc0/6752648/dbf519cb381c/1518-8787-rsp-53-77-gf02-pt.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc0/6752648/e0c713e22eb3/1518-8787-rsp-53-77-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc0/6752648/28ba8c39c27e/1518-8787-rsp-53-77-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc0/6752648/a70186751180/1518-8787-rsp-53-77-gf01-pt.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfc0/6752648/dbf519cb381c/1518-8787-rsp-53-77-gf02-pt.jpg

相似文献

1
Predictive model of unfavorable outcomes for multidrug-resistant tuberculosis.多药耐药结核病不良结局预测模型。
Rev Saude Publica. 2019 Sep 23;53:77. doi: 10.11606/s1518-8787.2019053001151. eCollection 2019.
2
High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.2000-2003 年南非夸祖鲁-纳塔尔省耐多药结核病患者的高治疗失败率和高失访率。
Int J Tuberc Lung Dis. 2010 Apr;14(4):413-9.
3
Clinical evolution of a group of patients with multidrug-resistant TB treated at a referral center in the city of Rio de Janeiro, Brazil.在巴西里约热内卢市一家转诊中心接受治疗的一组耐多药结核病患者的临床病程。
J Bras Pneumol. 2009 Jan;35(1):54-62. doi: 10.1590/s1806-37132009000100008.
4
Predictors of poor treatment outcomes in multidrug-resistant tuberculosis patients: a retrospective cohort study.耐多药结核病患者不良治疗结局的预测因素:一项回顾性队列研究。
Clin Microbiol Infect. 2018 Jun;24(6):612-617. doi: 10.1016/j.cmi.2017.09.012. Epub 2017 Sep 29.
5
Factors associated with loss to follow-up and death in cases of drug-resistant tuberculosis (DR-TB) treated at a reference center in Rio de Janeiro, Brazil.在巴西里约热内卢一家参考中心接受治疗的耐多药结核病(DR-TB)病例中,与失访和死亡相关的因素。
Cad Saude Publica. 2018 May 10;34(5):e00048217. doi: 10.1590/0102-311X00048217.
6
A DECADE TREND OF MULTIDRUG RESISTANT TUBERCULOSIS IN SÃO PAULO STATE, BRAZIL.巴西圣保罗州耐多药结核病的十年趋势
Rev Inst Med Trop Sao Paulo. 2016 Nov 3;58:77. doi: 10.1590/S1678-9946201658077.
7
Risk Factors for Multidrug-resistant Tuberculosis.耐多药结核病的危险因素
Acta Med Indones. 2018 Jan;50(1):1-2.
8
Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia.埃塞俄比亚西北部耐多药结核病患者的治疗结果
Trop Med Int Health. 2017 Mar;22(3):351-362. doi: 10.1111/tmi.12826. Epub 2017 Jan 6.
9
Primary bacillary resistance in multidrug-resistant tuberculosis and predictive factors associated with cure at a referral center in São Paulo, Brazil.巴西圣保罗一家转诊中心耐多药结核病的原发性杆菌耐药性及与治愈相关的预测因素
J Bras Pneumol. 2019 Mar 11;45(2):e20180075. doi: 10.1590/1806-3713/e20180075.
10
Predictors and mortality associated with treatment default in pulmonary tuberculosis.与肺结核治疗中断相关的预测因素和死亡率。
Int J Tuberc Lung Dis. 2010 Apr;14(4):454-63.

引用本文的文献

1
Spatial clusters of risk and cartography of care for drug-resistant tuberculosis.耐多药结核病风险的空间聚集与照护制图
Rev Saude Publica. 2025 Jun 30;59:e11. doi: 10.11606/s1518-8787.2025059006489. eCollection 2025.
2
Applying a Combined Model to Evaluate the Risk of Poor Treatment Outcomes in Rifampicin Resistant Tuberculosis Patients: A Multicenter Retrospective Study.应用联合模型评估耐利福平结核病患者治疗效果不佳的风险:一项多中心回顾性研究
Infect Drug Resist. 2024 Nov 29;17:5287-5298. doi: 10.2147/IDR.S491910. eCollection 2024.
3
Prognostication of treatment non-compliance among patients with multidrug-resistant tuberculosis in the course of their follow-up: a logistic regression-based machine learning algorithm.

本文引用的文献

1
Hearing loss with kanamycin treatment for multidrug-resistant tuberculosis in Bangladesh.孟加拉国使用卡那霉素治疗耐多药结核病时出现的听力损失。
Eur Respir J. 2018 Mar 22;51(3). doi: 10.1183/13993003.01778-2017. Print 2018 Mar.
2
Social support a key factor for adherence to multidrug-resistant tuberculosis treatment.社会支持是耐多药结核病治疗依从性的关键因素。
Indian J Tuberc. 2018 Jan;65(1):41-47. doi: 10.1016/j.ijtb.2017.05.003. Epub 2017 Jun 2.
3
Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis.
耐多药结核病患者随访期间治疗不依从性的预测:一种基于逻辑回归的机器学习算法
Front Digit Health. 2023 May 9;5:1165222. doi: 10.3389/fdgth.2023.1165222. eCollection 2023.
4
Development and validation of a prediction model for unsuccessful treatment outcomes in patients with multi-drug resistance tuberculosis.开发和验证多药耐药结核病患者治疗结局不良的预测模型。
BMC Infect Dis. 2023 May 5;23(1):289. doi: 10.1186/s12879-023-08193-0.
5
Factors of abandonment of tuberculosis treatment in the public health network.公共卫生网络中结核病治疗的放弃因素。
Rev Saude Publica. 2023 Apr 14;57:8. doi: 10.11606/s1518-8787.2023057004454. eCollection 2023.
6
Factors Associated with the Abandonment of Tuberculosis Treatment in Brazil: A Systematic Review.与巴西结核病治疗中断相关的因素:系统评价。
Rev Soc Bras Med Trop. 2023 Jan 23;56. doi: 10.1590/0037-8682-0155-2022. eCollection 2023.
7
A Scoring System Based on Laboratory Parameters and Clinical Features to Predict Unfavorable Treatment Outcomes in Multidrug- and Rifampicin-Resistant Tuberculosis Patients.一种基于实验室参数和临床特征的评分系统,用于预测耐多药和耐利福平结核病患者的不良治疗结局
Infect Drug Resist. 2023 Jan 10;16:225-237. doi: 10.2147/IDR.S397304. eCollection 2023.
8
Development and validation of a nomogram for the prediction of late culture conversion among multi-drug resistant tuberculosis patients in North West Ethiopia: An application of prediction modelling.在埃塞俄比亚西北部,针对耐多药结核病患者,开发并验证一种列线图以预测其晚期培养转归:预测模型的应用。
PLoS One. 2022 Aug 10;17(8):e0272877. doi: 10.1371/journal.pone.0272877. eCollection 2022.
9
Development and Validation of a Nomogram for the Prediction of Unfavorable Treatment Outcome Among Multi-Drug Resistant Tuberculosis Patients in North West Ethiopia: An Application of Prediction Modelling.埃塞俄比亚西北部耐多药结核病患者不良治疗结局预测列线图的开发与验证:预测模型的应用
Infect Drug Resist. 2022 Jul 21;15:3887-3904. doi: 10.2147/IDR.S372351. eCollection 2022.
10
Laboratory-based study of drug resistance and genotypic profile of multidrug-resistant tuberculosis isolates in Salvador, Bahia, Brazil.巴西萨尔瓦多基于实验室的耐药性和耐多药结核分枝杆菌分离株基因谱研究。
Rev Soc Bras Med Trop. 2022 Jul 25;55:e00132022. doi: 10.1590/0037-8682-0013-2022. eCollection 2022.
巴西耐多药结核病患者的治疗结果:一项回顾性队列分析。
BMC Infect Dis. 2017 Nov 14;17(1):718. doi: 10.1186/s12879-017-2810-1.
4
Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients.耐多药结核病患者中期治疗结果不佳的预测因素。
BMC Infect Dis. 2017 Sep 29;17(1):655. doi: 10.1186/s12879-017-2746-5.
5
Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China.中国湖南省耐多药和广泛耐药结核病患者的治疗结果
BMC Infect Dis. 2017 Aug 16;17(1):573. doi: 10.1186/s12879-017-2662-8.
6
Treatment outcomes of multidrug-resistant tuberculosis patients in Zhejiang, China, 2009-2013.2009-2013 年中国浙江地区耐多药结核病患者的治疗效果。
Clin Microbiol Infect. 2018 Apr;24(4):381-388. doi: 10.1016/j.cmi.2017.07.008. Epub 2017 Jul 13.
7
Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study.估算印度、菲律宾、俄罗斯和南非耐多药及广泛耐药结核病的未来负担:一项数学建模研究
Lancet Infect Dis. 2017 Jul;17(7):707-715. doi: 10.1016/S1473-3099(17)30247-5. Epub 2017 May 9.
8
Multidrug-resistant tuberculosis treatment programmes insufficiently consider comorbid mental disorders.耐多药结核病治疗方案对合并存在的精神障碍考虑不足。
Int J Tuberc Lung Dis. 2017 Jun 1;21(6):603-609. doi: 10.5588/ijtld.17.0135.
9
Clinical trial research in focus: overcoming barriers in MDR-TB clinical trials.聚焦临床试验研究:克服耐多药结核病临床试验中的障碍
Lancet Respir Med. 2017 Apr;5(4):247-248. doi: 10.1016/S2213-2600(17)30091-7.
10
A DECADE TREND OF MULTIDRUG RESISTANT TUBERCULOSIS IN SÃO PAULO STATE, BRAZIL.巴西圣保罗州耐多药结核病的十年趋势
Rev Inst Med Trop Sao Paulo. 2016 Nov 3;58:77. doi: 10.1590/S1678-9946201658077.